Clinical Trial Update: Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine and irinotecan for metastatic kidney cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED